Literature DB >> 9878348

The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1.

A Bochkarev1, E Bochkareva, L Frappier, A M Edwards.   

Abstract

Epstein-Barr nuclear antigen 1 (EBNA1) binds to four recognition sites in the minimal origin of latent DNA replication of Epstein-Barr virus and activates latent-phase replication of the viral genomes. Two of these EBNA1 binding sites become sensitive to permanganate oxidation when bound by the DNA binding and dimerization domains of EBNA1. We have previously solved the co-crystal structure of this EBNA1 fragment bound to a consensus recognition site that is not sensitive to permanganate oxidation (CS). To understand the structural difference that underlies the permanganate sensitivity of EBNA1 binding sites, we have now solved the crystal structure of the EBNA1 DNA-binding and dimerization domains bound to a permanganate-sensitive site (CSA/T). Comparisons of permanganate-sensitive and insensitive EBNA1-DNA complexes have revealed only minor differences in protein and DNA structures. In the EBNA1-CSA/T structure, interstrand H-bonds for three consecutive base-pairs centered over the permanganate-sensitive thymine base are lengthened relative to the corresponding bonds in the EBNA1-CS complex, and three potential intrastrand H-bonds were observed between adjacent bases. We also observed that both the CS and CSA/T sequences are overwound by EBNA1 in the vicinity of the permanganate-sensitive thymine base. Finally, we show that the permanganate-sensitive thymine base in the CSA/T-EBNA1 complex is more accessible to solvent than the corresponding T in the EBNA-CS complex. Copyright 1998 Academic Press

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878348     DOI: 10.1006/jmbi.1998.2247

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth.

Authors:  M S Kang; S C Hung; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

2.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA.

Authors:  Lai-Yee Wong; Angus C Wilson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Modeling the Lac repressor-operator assembly: the influence of DNA looping on Lac repressor conformation.

Authors:  David Swigon; Bernard D Coleman; Wilma K Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

4.  Epstein-Barr nuclear antigen 1 (EBNA1)-dependent recruitment of origin recognition complex (Orc) on oriP of Epstein-Barr virus with purified proteins: stimulation by Cdc6 through its direct interaction with EBNA1.

Authors:  Kenji Moriyama; Naoko Yoshizawa-Sugata; Chikashi Obuse; Toshiki Tsurimoto; Hisao Masai
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

5.  The minimal replicator of Epstein-Barr virus oriP.

Authors:  J L Yates; S M Camiolo; J M Bashaw
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance.

Authors:  Myung-Soo Kang; Eun Kyung Lee; Vishal Soni; Timothy A Lewis; Angela N Koehler; Viswanathan Srinivasan; Elliott Kieff
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

7.  Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.

Authors:  J M Bashaw; J L Yates
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.

Authors:  Eriko Ohsaki; Keiji Ueda; Shuhei Sakakibara; Eunju Do; Kaori Yada; Koichi Yamanishi
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening.

Authors:  Ning Li; Scott Thompson; David C Schultz; Weiliang Zhu; Hualiang Jiang; Cheng Luo; Paul M Lieberman
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

10.  EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.

Authors:  Feroz Sarkari; Teresa Sanchez-Alcaraz; Shan Wang; Melissa N Holowaty; Yi Sheng; Lori Frappier
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.